Genome-Wide Association Study Identifies a Novel Locus Contributing to Type 2 Diabetes Susceptibility in Sikhs of Punjabi Origin From India

Author(s): Saxena R, Saleheen D, Been LF, Garavito ML, Braun T, et al.

Abstract

We performed a genome-wide association study (GWAS) and a multistage meta-analysis of type 2 diabetes (T2D) in Punjabi Sikhs from India. Our discovery GWAS in 1,616 individuals (842 case subjects) was followed by in silico replication of the top 513 independent single nucleotide polymorphisms (SNPs) (P < 10⁻³) in Punjabi Sikhs (n = 2,819; 801 case subjects). We further replicated 66 SNPs (P < 10⁻⁴) through genotyping in a Punjabi Sikh sample (n = 2,894; 1,711 case subjects). On combined meta-analysis in Sikh populations (n = 7,329; 3,354 case subjects), we identified a novel locus in association with T2D at 13q12 represented by a directly genotyped intronic SNP (rs9552911, P = 1.82 × 10⁻⁸) in the SGCG gene. Next, we undertook in silico replication (stage 2b) of the top 513 signals (P < 10⁻³) in 29,157 non-Sikh South Asians (10,971 case subjects) and de novo genotyping of up to 31 top signals (P < 10⁻⁴) in 10,817 South Asians (5,157 case subjects) (stage 3b). In combined South Asian meta-analysis, we observed six suggestive associations (P < 10⁻⁵ to < 10⁻⁷), including SNPs at HMG1L1/CTCFL, PLXNA4, SCAP, and chr5p11. Further evaluation of 31 top SNPs in 33,707 East Asians (16,746 case subjects) (stage 3c) and 47,117 Europeans (8,130 case subjects) (stage 3d), and joint meta-analysis of 128,127 individuals (44,358 case subjects) from 27 multiethnic studies, did not reveal any additional loci nor was there any evidence of replication for the new variant. Our findings provide new evidence on the presence of a population-specific signal in relation to T2D, which may provide additional insights into T2D pathogenesis.

Similar Articles

Type 2 diabetes: principles of pathogenesis and therapy

Author(s): Stumvoll M, Goldstein BJ, van Haeften TW

Alternative therapies for type 2 diabetes

Author(s): Dey L, Attele AS, Yuan CS

Brussels, Belgium: International Diabetes Federation

Author(s): International Diabetes Federation

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

Author(s): Wild S, Roglic G, Green A, Sicree R, King H

Prevalence of diabetes in Pakistan

Author(s): Shera AS, Jawad F, Maqsood A

Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53: 2504-2508

Author(s): Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, et al.

A narrative insight to maturity-onset diabetes of the young

Author(s): Kanwal SF, Fazal S, Muhammad Ismail, Nighat Naureen

[MODY type diabetes: overview and recent findings]

Author(s): Ben Khelifa S, Barboura I, Dandana A, Ferchichi S, Miled A

HLA-A, -B, and -DR associations in type 1 diabetes mellitus with onset after age forty

Author(s): Pittman WB, Acton RT, Barger BO, Bell DS, Go RC, et al.

Latent autoimmune diabetes in adults (LADA) should be less latent

Author(s): Fourlanos S, Dotta F, Greenbaum CJ, Palmer JP, Rolandsson O, et al.

Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes

Author(s): Cervin C, Lyssenko V, Bakhtadze E, Lindholm E, Nilsson P, et al.

Genetics of type 2 diabetes

Author(s): Owen KR, McCarthy MI

The emerging genetic architecture of type 2 diabetes

Author(s): Doria A, Patti ME, Kahn CR

Genome-wide association studies in type 2 diabetes

Author(s): McCarthy MI, Zeggini E

Type 2 diabetes: new genes, new understanding

Author(s): Prokopenko I, McCarthy MI, Lindgren CM

Type 2 Diabetes Genetics: Beyond GWAS

Author(s): Sanghera DK, Blackett PR

A genome-wide association study identifies novel risk loci for type 2 diabetes

Author(s): Sladek R, Rocheleau G, Rung J, Dina C, Shen L, et al.

Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels

Author(s): Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research, Saxena R, Voight BF, et al.

A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants

Author(s): Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, et al.

A variant in CDKAL1 influences insulin response and risk of type 2 diabetes

Author(s): Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jonsdottir T, et al.

A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity

Author(s): Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, et al.

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis

Author(s): Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, et al.

Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci

Author(s): Saxena R, Elbers CC, Guo Y, Peter I, Gaunt TR, et al.

Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes

Author(s): Silander K, Mohlke KL, Scott LJ, Peck EC, Hollstein P, et al.

Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution

Author(s): Helgason A, Pálsson S, Thorleifsson G, Grant SF, Emilsson V, et al.

Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort

Author(s): van Vliet-Ostaptchouk JV, Shiri-Sverdlov R, Zhernakova A, Strengman E, van Haeften TW, et al.

Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study

Author(s): van Hoek M, Dehghan A, Witteman JC, van Duijn CM, Uitterlinden AG, et al.

Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus

Author(s): Maeda S, Tsukada S, Kanazawa A, Sekine A, Tsunoda T, et al.

Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus

Author(s): Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, et al.

Inflammatory markers and risk of developing type 2 diabetes in women

Author(s): Hu FB, Meigs JB, Li TY, Rifai N, Manson JE

Therapy with oral antidiabetic drugs: applied pharmacogenetics

Author(s): Holstein A, Seeringer A, Kovacs P

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action

Author(s): Shu Y, Sheardown SA, Brown C, Owen RP, Zhang S, et al.

Pharmacogenetics of Anti-Diabetes Drugs

Author(s): Distefano JK, Watanabe RM

Pharmacogenetics of oral antidiabetic treatment

Author(s): Schroner Z, Javorsky M, Kozarova M, Tkac I

Genetic basis of type 2 diabetes mellitus: implications for therapy

Author(s): Wolford JK, Vozarova de Courten B